Cardiovascular disease (CVD), principally heart disease and stroke, is the leading cause of death for both males and females in developed countries. Aspirin is the most widely used and tested antiplatelet drug in CVD, and it is proven to be the cornerstone of antiplatelet therapy in treatment and prevention of CVD in clinical trials in various populations. In acute coronary syndrome, thrombotic...

BACKGROUND Prospective cohort studies of prehypertension and the incidence of cardiovascular disease (CVD) are controversial after adjusting for other cardiovascular risk factors. This meta-analysis evaluated the association between prehypertension and CVD morbidity. METHODS Databases (PubMed, EMBASE and the Cochrane Library) and conference proceedings were searched for prospective cohort stu...

Background: Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Omega-3 fatty acids have been shown to have both anti-atherogenic and anti-inflammatory effects through inducing the expression and production of adipokines. Adipokines such as apelin, have been observed to play a protective role in the incidence and progression of CVD. The aim of this study was to assess the ...

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in patients with end-stage renal disease (ESRD). Both in dialysis and in transplant patients, CVD remains the leading cause of death. There is accumulating evidence that the increase in CVD burden is present in patients prior to dialysis, due to both conventional risk factors as well as those specific to kidney di...

Patients with Type 2 diabetes mellitus (T2DM) have increased cardiovascular disease (CVD) risk. The use of statins significantly reduces the rate of CVD events but many T2DM patients, especially those with mixed dyslipidaemia (MD), have residual CVD risk. The use of fibrates, which improve triglyceride and high-density lipoprotein cholesterol levels, is beneficial for the treatment of patients ...

The American Heart Association (AHA) Nutrition Committee developed a behavioral roundtable to address cardiovascular disease (CVD) disparities, with a focus on the primary prevention of obesity. This roundtable considered the preventable differences in the indicators of health of different population groups, often defined by race, ethnicity, sex, educational level, socioeconomic status, and geo...

BACKGROUND In rural and remote Australia, cardiovascular mortality and morbidity rates are higher than metropolitan rates.This study analysed cardiovascular and other chronic disease risk factors and related health behaviours by occupational status, to determine whether agricultural workers have higher cardiovascular disease (CVD) risk than other rural workers. METHODS Cross-sectional surveys...

The leading cause of death among people around the world is cardiovascular disease (CVD). In order to prevent patients from other damages, precise diagnostics CVD on time a crucial factor. Researcher workers are inspired apply machine learning (ML) for accurate and quick diagnosis CVD. ML algorithm extracts patterns hidden relationships in medical dataset detecting or predicting development. Bu...

Cardiovascular disease (CVD) is the most common cause of death in patients with chronic kidney disease (CKD). We report the baseline cardiovascular characteristics of 2,238 participants by using the data of the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) study. The cohort comprises 5 subcohorts according to the cause of CKD: glomerulonephritis (GN), diabe...

Blacks have a disproportionately higher risk and earlier onset of heart failure (HF) and cardiovascular mortality, relative to the overall American population. A prime contributor to this racial disparity is a higher prevalence and earlier onset of cardiometabolic disease, including obesity, hypertension, diabetes mellitus, and physical inactivity. Professional guidelines reinforcing ideal card...